{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:59:18Z","timestamp":1785437958961,"version":"3.56.0"},"reference-count":28,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tianjin Medical University Cancer Institute & Hospital","award":["358-2022-11"],"award-info":[{"award-number":["358-2022-11"]}]},{"name":"Tianjin Medical University Cancer Institute & Hospital","award":["358-2023-3"],"award-info":[{"award-number":["358-2023-3"]}]},{"award":["358-2022-11"],"award-info":[{"award-number":["358-2022-11"]}],"id":[{"id":"https:\/\/ror.org\/0152hn881","id-type":"ROR","asserted-by":"publisher"}]},{"award":["358-2023-3"],"award-info":[{"award-number":["358-2023-3"]}],"id":[{"id":"https:\/\/ror.org\/0152hn881","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background and purpose: Organ-preservation strategies are increasingly being incorporated into rectal cancer management, but the role of HDR endorectal\/endoluminal brachytherapy boost remains less well defined than that of broader non-operative treatment pathways. Existing literature is frequently mixed with contact X-ray brachytherapy series, neoadjuvant protocols with planned surgery, or heterogeneous watch-and-wait cohorts, limiting the interpretation of this specific strategy. Materials and methods: We performed a PROSPERO-registered systematic review and meta-analysis of studies evaluating definitive-intent external beam radiotherapy (EBRT), with or without chemotherapy, followed by HDR endorectal\/endoluminal brachytherapy boost in histologically confirmed rectal adenocarcinoma managed without planned surgery. Pooled analyses were performed for clinical complete response (cCR) and late grade \u22653 gastrointestinal (GI) toxicity. Regrowth\/local failure outcomes were synthesized descriptively because of heterogeneity in endpoint definitions, denominator selection, and follow-up structure. Results: Six studies were included in the quantitative evidence base, with one additional small feasibility report summarized narratively. The pooled cCR proportion was 69.2% (95% confidence interval [CI], 43.7\u201386.6). The pooled proportion of late grade \u22653 GI toxicity was 18.1% (95% CI, 10.9\u201328.6). Reported regrowth\/local failure outcomes were not suitable for formal pooling because of inconsistent definitions, differing denominator structures, and non-uniform follow-up frameworks across studies. Conclusion: Current evidence suggests that EBRT plus HDR endorectal\/endoluminal brachytherapy boost may represent a selective organ-preservation strategy for carefully chosen patients with rectal adenocarcinoma, particularly where surgery is not feasible or not desired. Its broader clinical use remains limited not only by the small size of the evidence base, but also by fragmented endpoint definitions, inconsistent denominator reporting, and insufficiently standardized durable local-control outcomes. These findings support cautious interpretation of the current evidence and highlight priorities for future prospective studies in rectal cancer management.<\/jats:p>","DOI":"10.3390\/cancers18091494","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:01:39Z","timestamp":1778140899000},"page":"1494","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HDR Endorectal\/Endoluminal Brachytherapy Boost in Rectal Organ Preservation: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6748-5629","authenticated-orcid":false,"given":"Yuanjie","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin 300060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin 300060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin 300060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China"},{"name":"Tianjin\u2019s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin 300060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","article-title":"Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Hofheinz","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.6004\/jnccn.2024.0041","article-title":"NCCN Guidelines\u00ae Insights: Rectal Cancer, Version 3.2024","volume":"22","author":"Benson","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e230146","DOI":"10.1001\/jamasurg.2023.0146","article-title":"Long-Term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait Approach","volume":"158","author":"Custers","year":"2023","journal-title":"JAMA Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): An international multicentre registry study","volume":"391","author":"Hilling","year":"2018","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: A systematic review and meta-analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-Term Results of Organ Preservation in Patients with Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): A phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1111\/cas.15959","article-title":"High-dose rate endorectal brachytherapy for rectal cancer: A state-of-the-art review","volume":"114","author":"Cheng","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Vuong, T., Garant, A., Vendrely, V., Nout, R., Martin, A.-G., Enger, S.A., Podgorsak, E., Moftah, B., and Devic, S. (2022). Image-Guided Brachytherapy for Rectal Cancer: Reviewing the Past Two Decades of Clinical Investigation. Cancers, 14.","DOI":"10.3390\/cancers14194846"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"110960","DOI":"10.1016\/j.radonc.2025.110960","article-title":"Endorectal high-dose-rate brachytherapy boost in rectal cancer: Results of the prospective cohort NOM-3 study on the watch-and-wait strategy","volume":"209","author":"Pietrzak","year":"2025","journal-title":"Radiother. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ijrobp.2019.08.042","article-title":"Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients with Rectal Cancer","volume":"105","author":"Garant","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijrobp.2017.01.033","article-title":"Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients with Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study","volume":"98","author":"Rijkmans","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(20)30557-X","article-title":"Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: A retrospective, international, multicentre registry study","volume":"22","author":"Fernandez","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/bjs\/znad051","article-title":"Watch and wait after neoadjuvant treatment in rectal cancer: Comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)","volume":"110","author":"Temmink","year":"2023","journal-title":"Br. J. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"key":"ref_17","first-page":"2127","article-title":"Methodological quality of case series studies: An introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid. Synth."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Garant, A., Vasilevsky, C.-A., Boutros, M., Khosrow-Khavar, F., Kavan, P., Diec, H., Groseilliers, S.D., Faria, J., Ferland, E., and Pelsser, V. (2022). MORPHEUS Phase II\u2013III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results. Cancers, 14.","DOI":"10.3390\/cancers14153665"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00066-022-01931-4","article-title":"Image-guided high-dose-rate brachytherapy for rectal cancer: Technical note and first clinical experience on an organ-preserving approach","volume":"198","author":"Fleischmann","year":"2022","journal-title":"Strahlenther. Onkol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00066-020-01612-0","article-title":"Toxicity outcome of endorectal brachytherapy boost in medically inoperable patients","volume":"196","author":"Chiang","year":"2020","journal-title":"Strahlenther. Onkol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5114\/jcb.2017.69335","article-title":"Inflatable multichannel rectal applicator for adaptive image-guided endoluminal high-dose-rate rectal brachytherapy: Design, dosimetric characteristics, and first clinical experiences","volume":"9","author":"Schmid","year":"2017","journal-title":"J. Contemp. Brachyther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: A prospective observational study","volume":"16","author":"Appelt","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_26","first-page":"68","article-title":"Emerging Role of Brachytherapy in the Non-Operative Management of Rectal Cancer","volume":"18","author":"Zhang","year":"2022","journal-title":"Curr. Color. Cancer Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Roviello, F., Andreucci, E., Carbone, L., Calomino, N., Piccioni, S., Bobbio, L., Piagnerelli, R., Fontani, A., and Marrelli, D. (2025). Preoperative Injection of Indocyanine Green Fluorescence at the Anorectal Junction Safely Identifies the Inferior Mesenteric Artery in a Prospective Case-Series Analysis of Colorectal Cancer Patients. Gastrointest. Disord., 7.","DOI":"10.3390\/gidisord7040076"},{"key":"ref_28","first-page":"296","article-title":"Local excision for early rectal cancer: Transanal endoscopic microsurgery and beyond","volume":"6","author":"Althumairi","year":"2015","journal-title":"J. Gastrointest. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/9\/1494\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:21:36Z","timestamp":1778502096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/9\/1494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cancers18091494"],"URL":"https:\/\/doi.org\/10.3390\/cancers18091494","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]}}}